Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.
Feder A, Brown O, Rutter S, Cahn L, Overbey J, Seeley S, Yu A, Bonanno P, Fremont R, Delgado A, Jha M, Costi S, Yehuda R, Schiller D, Pietrzak R, Charney D, Sloan D, Murrough J. Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial. The Journal Of Clinical Psychiatry 2025, 86 PMID: 40215385, DOI: 10.4088/jcp.24m15622.Peer-Reviewed Original ResearchConceptsChronic posttraumatic stress disorderPosttraumatic stress disorderKetamine infusionPosttraumatic stress disorder symptom severityClinician-Administered PTSD ScalePosttraumatic stress disorder symptomsDSM-5</i>Written Exposure TherapyOpen-label clinical trialIntravenous ketamine infusionSevere symptom levelsPTSD ScaleCAPS-5Exposure therapyStress disorderOpen-label trialSymptom levelsSymptom severityTreatment respondersPreliminary efficacyClinical trialsPreliminary findingsCombined treatmentLarge-scale randomized controlled trialsRandomized Controlled Trials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply